The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Off treatment survival (OTS) in patients (pts) with advanced melanoma after anti-PD1 therapy.
Shelly Ann Christiansen
No Relationships to Disclose
David Swoboda
No Relationships to Disclose
Kellie Gardner
No Relationships to Disclose
Suthee Rapisuwon
Research Funding - Bristol-Myers Squibb
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Aduro Biotech; Agenus; Alexion Pharmaceuticals; Argos Therapeutics; Array BioPharma; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Celldex; Eisai; Exelixis; Genentech; Glactone Pharma; Idera; Merck; Nektar; Novartis; Peleton; Pfizer; X4 Pharma
Geoffrey Thomas Gibney
Consulting or Advisory Role - Genentech/Roche; Genentech/Roche; Incyte; Newlink Genetics; Novartis
Speakers' Bureau - Genentech/Roche; Merck